Kura Oncology’s Brian T. Powl sells 24,450 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kura Oncology, Inc. Chief Commercial Officer Brian T. Powl reported direct sales of 24,450 common shares on November 16 and 17, 2026. The November 16 sale covered 9,196 shares at $7.44 per share to cover taxes associated with vesting of an RSU received on November 13, 2025. On November 17, Powl sold 15,254 shares at a weighted average $7.45 per share under a Rule 10b5-1 trading plan adopted May 22, 2026; executions ranged from $7.24 to $7.74. He also acquired 896 shares through the Employee Stock Purchase Plan on November 17.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F2, F3, F4 | 15,254 | $7.45 | $114K |
| Sale | Common Stock F1 | 9,196 | $7.44 | $68K |
Footnotes (4)
- F1. Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated November 13, 2025.
- F2. The shares sold were acquired by the Reporting Person upon vesting of restricted stock units on November 13, 2026. The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026.
- F3. This transaction was executed in multiple trades at prices ranging from $7.24 to $7.74. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. 896 shares were acquired on November 17, 2026 pursuant to the Issuer's Employee Stock Purchase Plan.
Key Figures
Key Terms
sell-to cover financial
restricted stock units financial
Rule 10b5-1 trading plan financial
Employee Stock Purchase Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Was Brian T. Powl's November 17 KURA sale made under a 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.